Abstract
Monitoring patients with burn wounds for infection is standard practice because failure to rapidly and specifically identify a pathogen can result in poor clinical outcomes, including death. Therefore, a method that facilitates detection and identification of pathogens in situ within minutes of biopsy would be a significant benefit to clinicians. Mass spectrometry is rapidly becoming a standard tool in clinical settings, capable of identifying specific pathogens from complex samples. Imaging mass spectrometry (IMS) expands the information content by enabling spatial resolution of biomarkers in tissue samples as in histology, without the need for specific stains/antibodies. Herein, a murine model of thermal injury was used to study infection of burn tissue by Pseudomonas aeruginosa. This is the first use of IMS to detect P. aeruginosa infection in situ from thermally injured tissue. Multiple molecular features could be spatially resolved to infected or uninfected tissue. This demonstrates the potential use of IMS in a clinical setting to aid doctors in identifying both presence and species of pathogens in tissue.
Keywords: Burn injuries, Imaging mass spectrometry, Pseudomonas aeruginosa
1. Introduction
Burn injuries are one of the most common forms of trauma and represent a major health concern as burn-related infections are a significant cause of morbidity and mortality [1,2]. In the United States alone, there are approximately 1.2 million burn injuries each year, primarily among young children and the elderly [3]. Roughly 100,000 of these injuries are classified as severe, requiring hospitalization, and five percent result in death of the patient [3,4]. The average cost to treat a hospitalized burn patient is $200,000, and it is estimated that $18 billion is spent treating burn patients in the United States alone each year [3,5]. Compounding the economic burden of burn injuries is the increased risk of wound infection and sepsis, the primary cause of mortality in burn patients [6–8].
Under normal circumstances, healthy skin tissue acts as a natural barrier to microbes. However, in burn injuries this function is compromised, providing pathogens an opportunity to establish an infection in the patient. Pseudomonas aeruginosa is one of the most common bacterial isolates recovered from burn wounds and is associated with the highest mortality rate in burn patients [9,10]. This is attributed to the fact that P. aeruginosa is equipped with a battery of virulence factors that facilitate rapid colonization and dissemination when the epithelial barrier is compromised, as is observed in patients with severe burns [11–13]. The progression from skin to vascular infection and eventual sepsis has been shown to be as rapid as 24 hours [14]. Thus, P. aeruginosa poses a serious threat to patients with impaired defense mechanisms, and early detection techniques are critical to reduce the mortality rates stemming from sepsis.
Antimicrobial agents can be used to treat patients with P. aeruginosa infections, but the infections can be difficult to detect in a timely fashion with current methodologies. Despite the prevalence of pathogens such as P. aeruginosa in burn injuries, currently there are no rapid techniques for in situ detection, identification, or assessment of distribution in a clinical setting [15]. Technical limitations in the evaluation of potentially infected tissue from clinical samples currently prevent broad and robust in situ detection and identification of pathogens. Current methods for the detection of pathogens require sampling of a patient’s wound by either swab or tissue biopsy [3]. Identification of burn wound pathogens is routinely performed using microbial culture techniques in the clinical microbiology laboratory, but novel methods including nucleic acid detection and antigen detection have been explored [3,16,17]. A major problem with these techniques is that the time required from biopsy to identification is often 24 hours or more [3]. Identifying and differentiating infecting organisms while preserving their in situ geography using histopathological techniques, such as fluorescence in situ hybridization or immunohistochemistry, is not a routine procedure for burn tissue as these techniques are limited because they detect only one or a few proteins or nucleic acid sequences at a time [3,17].
The use of matrix assisted laser desorption/ionization (MALDI) mass spectrometry (MS) is now routine for the identification of cultured bacteria in clinical microbiology [18,19]. However, cultivation of isolated organisms is required before MALDI MS can be used for routine pathogen identification. Along similar lines, MALDI imaging MS (MALDI-IMS) has been used to investigate biomarkers in situ. To date, this has been practiced strictly outside of the clinic. By rastering a laser across the tissue, mass spectra can be collected in an array. The ion intensities for individual mass-to-charge ratios are then visualized in a two dimensional image as a heat map [20]. However, there have not been any attempts in the literature to detect microorganisms or tissue infection directly from infected tissue sections using MALDI-IMS. Recently, we demonstrated the use of MALDI-IMS to investigate bacteria and antimicrobial agent distribution in an in vitro model [21]. In the current study, we applied MALDI-IMS to the in situ detection of P. aeruginosa infecting a burn wound using a well-studied thermal-injury mouse model [13,22,23]. This is the first report of detecting a pathogen in situ using MALDI-IMS directly from tissue sections.
2. Methods
2.1 Bacterial strains and growth conditions
P. aeruginosa strain PAO1 was used in this study [24]. Cultures of P. aeruginosa were grown aerobically in lysogeny broth (LB) at 37 °C, with shaking at 200 revolutions per minute (rpm). An aliquot of this overnight growth was transferred to fresh LB and incubated for 3 hours at 37°C with shaking at 200 rpm.
2.2 Mouse model of thermal injury
The thermally-injured mouse model was adapted from the burned-mouse model protocol described by Stieritz and Holder [14,25,26]. Burn experiments were conducted in adult female Swiss Webster mice (Charles River Laboratories) weighing between 20 to 25 g. The mice were anaesthetized by intraperitoneal injection of 0.4ml Nembutal at 5mg/ml (5% sodium pentobarbital; Oak Pharmaceuticals, Inc.) before their dorsum was shaved, and the hair cleanly removed with a depilatory agent (Nair™). The mice were then securely placed into a template with an opening (4.5 cm × 1.8 cm) designed to expose approximately 15% total body surface area (TBSA) of the animal’s dorsum to a thermal water bath. Thermal injury was induced by placing the exposed area of the shaved skin in 90 °C water for 10 seconds. This scald injury is non-lethal but induces a third-degree (full-thickness) burn. Immediately following thermal insult, mice received fluid replacement therapy via subcutaneous injection of 800 μL Lactated Ringer’s solution into the nape of the neck. Mice were then inoculated with a subcutaneous challenge of approximately 102 cells of P. aeruginosa in 100 μL phosphate-buffered saline (PBS) or 100 μL of PBS without bacteria. Where specified, non-injured mice served as a control and their backs were shaved and treated with a depilatory agent in parallel with thermally-injured mice. At 40 hours post burn and 5 days post burn, mice were euthanized by intracardiac injection of 200 μL (390 mg/mL) Fatal-Plus® (Vortech Pharmaceuticals, LTD.). Animals were treated humanely and in accordance with protocol #96020 approved by the Institutional Animal Care and Use Committee at Texas Tech University Health Sciences Center in Lubbock, Texas.
2.3 Preparation of P. aeruginosa inoculum for challenge in thermally-injured mice
P. aeruginosa inoculum for challenge in thermally injured mice were prepared as previously described [14,26]. Briefly, an aliquot from an overnight culture of P. aeruginosa was subcultured in fresh LB for approximately 3 hours at 37 °C, and then adjusted to an OD590 of 0.9 using sterile 1X PBS. After O.D. adjustment, a 1 mL aliquot of the subculture was pelleted, washed (twice) in 1X PBS, and then serially diluted (10-fold dilutions) in sterile 1X PBS. A 100 μL aliquot of the 10−5 dilution was used to inoculate each animal via subcutaneous injection directly into the burn wound. This dilution has previously been determined to contain approximately 2×102 to 3×102 colony forming units (CFU) of P. aeruginosa; this dose of the wild-type P. aeruginosa strain, PAO1, has been shown to cause 94 to 100% mortality in Swiss Webster mice by 48 hours post burn and infection [26]. The number of CFU in the pre-injection inoculum was verified by plating 100 μL of the inoculum on Pseudomonas isolation agar (BD Difco™).
2.4 Collection and sectioning of tissue samples
The embedding medium, 2% carboxymethyl cellulose (CMC) plus 5% gelatin, was selected because it is compatible with MALDI-IMS. This was prepared immediately prior to tissue collection. Briefly, CMC sodium salt (medium viscosity) (MP Biomedicals, LLC.) and 5% gelatin type A (ACROS Organics™) were combined in water in a 50 mL conical tube and heated in a standard microwave with intermittent stirring. The CMC + gelatin embedding mixture was then held at 65°C in a water bath. Individual tissue samples resected from the dorsum of burned mice (with or without infection) were resized to approximately 1 cm × 0.5 cm and positioned in a Tissue-tek® vinyl specimen Cryomold® (Sakura Finetek) containing CMC + gelatin embedding medium and then placed into a −80 °C freezer to solidify before sectioning (see Figure 1 for a schematic representation of re-orientation and sectioning procedures). Tissue from non-burned mice was resected from the center of the dorsum and prepared in parallel with burned tissue samples. Frozen samples embedded in CMC + gelatin were sectioned using an OTF5000 cryostat (Bright Instrument Co Ltd.) to a thickness of 20 μm and then directly transferred to a glass slide with an indium-tin oxide (ITO) coated surface (HTX Technologies). A positive control of P. aeruginosa culture was spotted onto the slide. Prepared slides were stored at −80 °C until matrix application.
Figure 1. MALDI-IMS experimental workflow.

Tissue from mice (healthy-control, burn-control, and burn-infected) were excised, embedded in carboxymethyl cellulose (CMC)/gelatin media, frozen, and sectioned. Tissue sections along with a control spot of culture PAO1 were placed on indium-tin oxide (ITO) coated glass slides. Slides were coated in 2,5-dihydroxybenzoic acid (DHB) matrix and MALDI-IMS data was acquired. Analysis of data was performed using flexImaging software (Bruker Daltonics) and MSiReader (North Carolina State University).
2.5 Matrix application for MALDI-IMS
Matrix application has been previously described [21]. Briefly, tissue sections on ITO glass slides were dehydrated in a desiccator for 30 minutes. A solution of 150 mg/mL 2,5-dihydroxybenzoic acid (DHB, Sigma) in 50% aqueous methanol and 0.05% formic acid (Sigma) was applied using an airbrush held approximately 25 cm from the slide. A spray time of 30 seconds with one minute of drying time between was used until 15 mL of matrix solution had been dispensed (roughly 15 passes). Slides were then dehydrated in a desiccator for 30 minutes and then analyzed by MALDI-IMS.
2.6 MALDI-IMS of burn-infected tissue sections
Imaging data was collected using a Bruker Autoflex III MALDI Time-of-Flight (TOF) mass spectrometer (Bruker Daltonics) equipped with a Smartbeam Nd:YAG laser (355 nm). The instrument was operated in positive ionization mode with the TOF in reflection mode. Calibration was performed before each image acquisition using a custom tune mix spotted onto the slide prior to matrix application (see Figure 2 for slide layout). The custom tune mix consisted of glutamine, histidine, phenylalanine, HEPES, SDS, and CHAPS. For data acquisition, spectra were collected in the mass range 50–1000 m/z by averaging 500 laser shots per pixel with a 150 μm lateral resolution using flexImaging v2.1 (Bruker Daltonics). Representative spectra for two pixels can be seen in Supplemental Figure 1. Data was exported as an IMG file (.img) from flexImaging and imported into MSiReader v0.06 (North Carolina State University) for visualization of images. The data set was normalized to total ion count. Initially, features which were unique to P. aeruginosa were found using the MSiReader peak finding function. Features which were present in the P. aeruginosa culture spot but not in the reference area were plotted as heat maps to verify their distribution was unique to P. aeruginosa. Additional features were identified by manually generating heat maps, each with the most abundant feature in a 0.5 Da bin window.
Figure 2. Optical image and MALDI-IMS heat map for ion 118.0/140.1 m/z from tissue 40 hours post infection.

Optical image of a slide with sectioned tissue and relevant controls after matrix application (upper panel). A heat map shows the location of ion 118.0/140.1 m/z based on intensity (lower panel). Labels denote samples in upper and lower panels. The scale bar in the lower panel shows the relative intensity of ions from all spectra collected.
3. Results and Discussion
The potential of MALDI-IMS as a diagnostic tool for monitoring infection in a burn wound was assessed using an in situ tissue model. A diagram depicting the workflow for MALDI-IMS analysis of infected tissue samples is shown in Figure 1. MALDI-IMS analysis of burn tissue inoculated with P. aeruginosa revealed a number of features that could be used for the in situ detection of infection (Table 1). Tentative identifications have been assigned to each unique feature based on mass matches to the Biocyc curated database for P. aeruginosa within a range of +/− 0.25 Da, which is the limit of accuracy of the MALDI system when imaging tissue sections. Additionally, several features in Table 1 were identified in an untargeted metabolomics analysis of P. aeruginosa in our lab using a high mass accuracy quadruple time-of-flight (Q-TOF) mass spectrometer (unpublished data).
Table 1.
Molecular features unique to burn-infected tissue.
| m/z | Tentative ID | Adduct |
|---|---|---|
| 74.0 | 2-iminoacetate | H |
| propioamide | H | |
| 118.0 | L-aspartate-semialdehyde | H |
| L-valine* | H | |
| 5-aminovalerate | H | |
| 140.1 | L-aspartate-semialdehyde | Na |
| L-valine | Na | |
| 5-aminovalerate | Na | |
| 148.1 | L-glutamate* | H |
| L-4-0hydroxyglutamate semialdehyde* | H | |
| O-acetyl-L-serine* | H | |
| taurine | Na | |
| (2-aminoethyl)-phosphenate* | H | |
| 5-methylcytosine | H | |
| 257.2 | β-D-ribosylnicotinate* | H |
| palmitate | H | |
| 272.2 | pyridoxine-5′-phosphate | Na |
| 338.1 | S-hydroxymethlglutatione | H |
| 367.9 | 15Z-tetracosenoate | H |
| guanosine 2′,3′-cyclic monophosphate | Na | |
| thiamin phosphate | Na |
denotes metabolites in LC-MS analysis of PAO1
The features listed in Table 1 were selected because they are unique to spectra collected from the P. aeruginosa control spot and tissue that was infected, suggesting these were metabolic signatures unique to P. aeruginosa or infected tissue. A heat map of ion 118.0 m/z illustrates the lack of signal in control tissues and a strong signal in both the P. aeruginosa control spot and infected tissue (Figure 2). Ion 140.1 m/z displays a similar distribution in the heat map to that of 118.0 m/z. This suggests that these mass-charge ratios represent the same molecular species with a hydrogen ion (118.0 m/z) or a sodium ion (140.1 m/z) associated with it. The control spot of P. aeruginosa shows a higher signal overall compared with tissue sections, because ion signals are coming only from the bacteria, rather than a mixture of P. aeruginosa and wound tissue. Heat maps were also generated for the remaining ions in Table 1 (Supplemental Figure 2).
The molecular features from Table 1 were highly reproducible, consistently appearing in tissue across experimental replicates (Figure 3). On the left are optical images of DHB coated tissue, where the arrows indicate the orientation of the tissue (see Figure 1), while the right panels show the heat map generated from the ion 118.0 m/z. The top panels are tissue excised from mice 40 hours post inoculation (Figure 3A,B), while the bottom panels are tissue excised from mice 5 days post inoculation (Figure 3C,D). Using this mouse model, it has been demonstrated that the bacterial load increases over time, exceeding 109 CFU/g tissue as early as 24 hours post burn and infection [13,22,23]. We observed that the relative intensity of the P. aeruginosa-specific molecular species also increased over time when examining the relative intensity of these molecules (Figure 3). This result indicates that MALDI-IMS could potentially be used to quantify the bacteria load present in situ [13,22,23].
Figure 3. Analysis of infected tissue.

Optical images (A and C) and heat map images showing the ion 118.0 (B and D) acquired from two separate mice during two separate experiments. The arrows show the orientation of the tissue based on the diagram in Figure 1. The tissue in the upper panels was excised 40 hours post inoculation while the lower panels represent tissue that was excised 5 days post inoculation. The heat maps shown in B and D show relative ion intensity, where blue is low and red is high.
The ability to spatially resolve ions across a tissue section using MALDI-IMS is this method’s hallmark and can be immensely helpful when monitoring the infection of tissue with respect to traditional methods that homogenize samples prior to analysis. A limitation of any analytical method is that low abundance molecular species can be obscured by background signals, or that sporadic noise could result in false positive signals. However, in our data, the signal to noise ratio was excellent for regions which displayed even low signal (blue regions in the heat maps displayed in Figure 3) relative to the rest of the image. No signal for ions of interest was found in control tissue spectra, while in the infected burn tissue ion intensity was at least five-fold greater than background. While the absolute abundance of the molecular species in the tissue sections was not determined, we have demonstrated that we can detect and spatially resolve sites of bacterial infection in burn tissue.
4. Conclusions
This is the first report to demonstrate that molecular-level imaging, specifically MALDI-IMS, can be used to delineate tissue infected with bacteria. We identified multiple molecular signals in situ that are present exclusively in infected tissue and positive P. aeruginosa controls, but are absent in uninfected tissue. The method described here of excising tissue for MALDI-IMS mimics a biopsy of tissue from a patient and does not require lengthy culturing of the pathogen. Additional work needs to be performed in order to determine the composition of the molecular signatures that have been identified, the maximum m/z range that could be used when acquiring MALDI-IMS spectra, whether or not polymicrobial infections could be identified to the organism level using MALDI-IMS, and if similar results can be obtained from human samples. We believe our method for the identification of bacterial infection in situ demonstrates a new method for detecting bacterial infections directly from infected tissue. This method of identification has the potential to bridge the gap between microbiological culture and histopathological analysis for the infected tissue, thereby aiding in the effective and timely treatment of bacterial infections.
Supplementary Material
Supplemental Figure 1. Representative spectra from PAO1 infected burn tissue. Two spectra representing two individual pixels taken during MALDI-IMS acquisition of burn tissue infected with PAO1. Each spectrum (or pixel) is the sum of 500 laser shots rastered within a 150 μm area. Spectra were acquired from the range 50–1000 m/z, as seen in the larger panels, with the inserts showing a zoom of the range from 50–300 m/z. Stars (*) in the inset denote peaks for features unique to PAO1 (Table 1).
Supplemental Figure 2. Additional MALDI-IMS heat map for ions unique to PAO1 from tissue 40 hours post infection. Optical image of a slide with sectioned tissue and relevant controls after matrix application (upper panel). Heat maps showing intensity and spatial distribution for additional ions from Table 1 in burn tissue infected with PAO1 (lower panels).
Highlights.
Imaging mass spectrometry (IMS) can be used to identify and localize bacterial infection of wounds.
Molecular markers unique to bacteria were found.
IMS could be used to assist clinical labs in rapid identification of infection.
Acknowledgments
The authors would like to thank Rebecca E. Tweedell for critical reading and editing of the manuscript throughout its evolution. BB received support from the National Science Foundation MCB102248. The Proteomics, Metabolomics, and Mass Spectrometry facility at MSU received support from the Murdock Charitable Trust and NIH 5P20RR02437 of the CoBRE program. Research reported in this publication was supported in part by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P20GM103474.
List of abbreviations
- CFU
colony forming units
- CMC
carboxymethyl cellulose
- DHB
2,5-dihydroxybenzoic acid
- IMS
imaging mass spectrometry
- ITO
indium-tin oxide
- LB
lysogeny broth
- MALDI
matrix-assisted laser desorption ionization
- MS
mass spectrometry
- PBS
phosphate buffered saline
- Q-TOF
quadrupole time-of-flight
- RPM
revolutions per minute
- TBSA
total body surface area
Footnotes
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
The authors declare that they have no competing interests.
References
- 1.Bahemia IA, Muganza A, Moore R, Sahid F, Menezes CN. Microbiology and antibiotic resistance in severe burns patients: A 5 year review in an adult burns unit. Burns. 2015;41:1536–1542. doi: 10.1016/j.burns.2015.05.007. [DOI] [PubMed] [Google Scholar]
- 2.Keen EF, Robinson BJ, Hospenthal DR, Aldous WK, Wolf SE, Chung KK, Murray CK. Incidence and bacteriology of burn infections at a military burn center. Burns. 2010;36:461–468. doi: 10.1016/j.burns.2009.10.012. [DOI] [PubMed] [Google Scholar]
- 3.Church DBCE, Elsayed SB, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev. 2006;19:403–434. doi: 10.1128/CMR.19.2.403-434.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Hunt JL. The 2000 Presidential Address: Back to the Future: The ABA and Burn Prevention. J Burn Care Rehabil. 2000;21:474–483. [PubMed] [Google Scholar]
- 5.Roth JJ, Hughes WB. The Essential Burn Unit Handbook. Quality Medical Publishin; St. Louis, MO: 2004. [Google Scholar]
- 6.Singer AJ, McClain SA. Persistent wound infection delays epidermal maturation and increases scarring in thermal burns. Wound Repair Regen. 2002;10:372–377. doi: 10.1046/j.1524-475x.2002.10606.x. [DOI] [PubMed] [Google Scholar]
- 7.Edwards R, Harding KG. Bacteria and wound healing. Curr Opin Infect Dis. 2004;17:91–96. doi: 10.1097/00001432-200404000-00004. [DOI] [PubMed] [Google Scholar]
- 8.Kennedy P, Brammah S, Wills E. Burns, biofilm and a new appraisal of burn wound sepsis. Burns. 2010;36:49–56. doi: 10.1016/j.burns.2009.02.017. [DOI] [PubMed] [Google Scholar]
- 9.Azzopardi EA, Azzopardi E, Camilleri L, Villapalos J, Boyce DE, Dziewulski P, Dickson WA, Whitaker IS. Gram negative wound infection in hospitalised adult burn patients-systematic review and metanalysis. PLoS One. 2014;9:e95042. doi: 10.1371/journal.pone.0095042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Bennett JE, Dolin R, Blaser MJ. Principles and Practices of Infectious Diseases. 8th. Elsevier Inc; 2015. [Google Scholar]
- 11.Turner KH, Everett J, Trivedi U, Rumbaugh KP, Whiteley M. Requirements for Pseudomonas aeruginosa Acute Burn and Chronic Surgical Wound Infection. PLoS Genet. 2014;10 doi: 10.1371/journal.pgen.1004518. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Berka RM, Gray GL, Vasil ML. Studies of phospholipase C (heat-labile hemolysin) in Pseudomonas aeruginosa. Infect Immun. 1981;34:1071–1074. doi: 10.1128/iai.34.3.1071-1074.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Rumbaugh KP, Griswold JA, Iglewski BH, Hamood AN. Contribution of Quorum Sensing to the Virulence of Pseudomonas aeruginosa in Burn Wound Infections. Infect Immun. 1999;67:5854–5862. doi: 10.1128/iai.67.11.5854-5862.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Schaber JA, Triffo WJ, Sang JS, Oliver JW, Hastert MC, Griswold JA, Auer M, Hamood AN, Rumbaugh KP. Pseudomonas aeruginosa forms biofilms in acute infection independent of cell-to-cell signaling. Infect Immun. 2007;75:3715–3721. doi: 10.1128/IAI.00586-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Vertes A, Hitchins V, Phillips KS. Analytical challenges of microbial biofilms on medical devices. Anal Chem. 2012;84:3858–3866. doi: 10.1021/ac2029997. [DOI] [PubMed] [Google Scholar]
- 16.Elsayed S, Gregson DB, Lloyd T, Crichton M, Church DL. Utility of Gram Stain for the Microbiological Analysis of Burn Wound Surfaces. Arch Pathol Lab Med. 2003;127:1485–1488. doi: 10.5858/2003-127-1485-UOGSFT. [DOI] [PubMed] [Google Scholar]
- 17.Lazcka O, Del Campo FJ, Muñoz FX. Pathogen detection: A perspective of traditional methods and biosensors. Biosens Bioelectron. 2007;22:1205–1217. doi: 10.1016/j.bios.2006.06.036. [DOI] [PubMed] [Google Scholar]
- 18.Sogawa K, Watanabe M, Sato K, Segawa S, Ishii C, Miyabe A, Murata S, Saito T, Nomura F. Use of the MALDI BioTyper system with MALDI-TOF mass spectrometry for rapid identification of microorganisms. Anal Bioanal Chem. 2011;400:1905–1911. doi: 10.1007/s00216-011-4877-7. [DOI] [PubMed] [Google Scholar]
- 19.Maier T, Kostrzewa M. Fast and reliable MALDI-TOF MS-based microorganism identification. Nat Methods. 2006;3:i–ii. [Google Scholar]
- 20.Walch A, Rauser S, Deininger SO, Höfler H. MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology. Histochem Cell Biol. 2008;130:421–434. doi: 10.1007/s00418-008-0469-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Hamerly T, Butler MH, Fisher ST, Hilmer JK, James GA, Bothner B. Mass spectrometry imaging of chlorhexidine and bacteria in a model wound. AIMS Med Sci. 2015;2:150–161. [Google Scholar]
- 22.Haynes A, Ruda F, Oliver J, Hamood AN, Griswold JA, Park PW, Rumbaugh KP. Syndecan 1 shedding contributes to Pseudomonas aeruginosa sepsis. Infect Immun. 2005;73:7914–7921. doi: 10.1128/IAI.73.12.7914-7921.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Haynes A, Rumbaugh KP, Park PW, Hamood AN, Griswold JA. Protamine sulfate reduces the susceptibility of thermally injured mice to Pseudomonas aeruginosa infection. J Surg Res. 2005;123:109–117. doi: 10.1016/j.jss.2004.07.251. [DOI] [PubMed] [Google Scholar]
- 24.Holloway BW, Krishnapillai V, Morgan AF. Chromosomal genetics of Pseudomonas. Microbiol Rev. 1979;43:73–102. doi: 10.1128/mr.43.1.73-102.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Stieritz DD, Holder IA. Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: description of a burned mouse model. J Infect Dis. 1975;131:688–691. doi: 10.1093/infdis/131.6.688. [DOI] [PubMed] [Google Scholar]
- 26.Rumbaugh KP, Griswold JA, Hamood AN. Contribution of the regulatory gene lasR to the pathogenesis of Pseudomonas aeruginosa infection of burned mice. J Burn Care Rehabil. 1999;20:42–49. doi: 10.1097/00004630-199901001-00008. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplemental Figure 1. Representative spectra from PAO1 infected burn tissue. Two spectra representing two individual pixels taken during MALDI-IMS acquisition of burn tissue infected with PAO1. Each spectrum (or pixel) is the sum of 500 laser shots rastered within a 150 μm area. Spectra were acquired from the range 50–1000 m/z, as seen in the larger panels, with the inserts showing a zoom of the range from 50–300 m/z. Stars (*) in the inset denote peaks for features unique to PAO1 (Table 1).
Supplemental Figure 2. Additional MALDI-IMS heat map for ions unique to PAO1 from tissue 40 hours post infection. Optical image of a slide with sectioned tissue and relevant controls after matrix application (upper panel). Heat maps showing intensity and spatial distribution for additional ions from Table 1 in burn tissue infected with PAO1 (lower panels).
